Font Size:
a
A
A
Keyword [Antagonist peptide]
Result: 1 - 18 | Page: 1 of 1
1.
The Study Of Endothelin Receptor Antagonists
2.
Design Of TNF-α Antagonists Based On The Interaction Between TNF-α And Neutralizing Monoclonal Antibody (Z12)
3.
Design Of Human Smaller Antibody Against TNF-α Based On Antibody Consensus Frameworks And Antagonist Peptides
4.
Potent Anti-tumor Effect And Mechanisms Of A Novel Antagonist Peptide Targeting HPV16E7
5.
Design And Synthesis Of Endothelin Receptor Antagonist
6.
Design And Synthesis Of Endothelin Receptor Antagonists
7.
The Mechanism And The Effects Of P7 On The Proliferation Of Colon Carcinoma Cells And Vascular Endothelial Cells Induced By Basic Fibroblast Growth Factor
8.
The Mechanism Of The BFGF Antagonist Peptide On BFGF-induced Proliferation Of Gastric Cancer Cells And Angiogenesis
9.
Mechanism Study Of P7Inhibiting Tumor Growth And Reversing Drug Resistance To Chemotherapy In Cancer Cells
10.
Studies Of BAFF Antagonist Peptide Based On The Structures Of TACI And BAFF
11.
Antagonist Peptide Design Of CCR1Based On VMIP-Ⅱ Simulated Peptide-cut And It’s Bioactivity Study
12.
Effects Of CD147 Antagonist Peptide And Matrix Metalloproteinase Inhibitor Doxycycline On Gallbladder Carcinoma Cell
13.
The Study Of Hydrostatin-SN10 From Sea Snake On The Anti-rheumatoid Arthritis
14.
Preliminary Pharmacodynamic Study Of Selective TNFR1 Antagonist Peptide Hydrostatin-SN10 In The Treatment Of Inflammatory Bowel Disease
15.
Construction Of Light-switchable A
2A
R Antagonistic Tool And The Role Of A
2A
R In The Impulsive Behavior
16.
A Study On The Effect Of The Number Of BAFF Antagonistic Peptides On Its Inhibitory Activity As A Peptide-Fc Fusion Protein
17.
The Function And Mechanisms Of Apolipoprotein J In The Progression Of Nonalcoholic Fatty Liver Disease
18.
Development Of A Therapeutic ApoJ Antagonist Peptide To Against Non-alcoholic Fatty Liver Disease
<<First
<Prev Next>
Last>>
Jump to
